Phase I Study Trends and Market Outlook (2016-2020)

Report Overview

Advertising agencies have become an integral part of a product’s commercialization.  From patient recruitment to brand marketing, ad agencies are responsible for a variety of activities that impact a product’s success in the marketplace.  In this report, ISR has compiled and analyzed extensive data around healthcare ad agencies that will allow stakeholders within the industry to make more informed decisions about how and to which ad agencies these services are outsourced.  103 decision-makers with experience working with ad agencies have weighed in to provide insight into their agency selection process.  They have provided feedback on 313 recent service encounters with 68 different ad agencies.

What you will learn:

• 4-year examination of the industry’s Phase I market dynamics, such as study volume and outsourced spend, analyzed by study design (Interventional studies and Observational research) and by study type (Post-marketing Safety studies, Health Economics and Outcomes Research, and Expanded Access studies)
• Average dollar value of outsourced Phase I studies and how this varies by sponsor size
• How large, mid-size, Phase I specialists, and AMCs are selected for patient vs. healthy volunteer studies
• Global geographic trends in the placement of Phase I studies

How you can use this report:

• Build your sales, marketing, and strategic plans using dependable industry figures
• Ensure your Phase I outsourcing practices are industry standard or better